| acetylation American amino group androgen receptor antitumor agent apoptosis aqueous aza-CdR azacytidine BCL-2 binding sites bisulfite bladder cancer cancer cells cancer chemotherapy cancer progression cancer therapy carcinogenesis CDKN2A cell cycle cell divisions cell growth cell proliferation cell viability chemical chemoprevention chip chromatin chromosome clinical trials COX-2 CpG dinucleotides CpG-islands cutaneous T-cell lymphoma cytidine Cytokine cytosine deacetylation deaminase deamination Delivery demethylating demethylation deoxycytidine | DNA methylation DNA sequence Dnmt DNMT1 DNMT3b dysplasia E-Cadherin Epigenetic Exon fibroblast growth factor Food gene expression gene silencing genetic code genome growth factor receptor histone deacetylase histones hormone human cell lines hydralazine hypermethylation hypomethylated hypomethylation ICAM immunohistochemistry instability interleukin-1 intron invasive kallikrein keratinocytes loss of heterozygosity lysine mammalian methyltransferase mice microRNAs miRNAs mouse mRNA muscle mutation nuclease | nucleoside inhibitors nucleosomes nucleotide sequence oligodeoxynucleotides oligonucleotides oncogenes oral administration p16 p21 p53 gene p53 protein PCR phenotype physiology PIG post-transcriptional prevention procainamide Prostate cancers prostate-specific antigen proto-oncogene PSA replication repression RNA polymerase RNAi secretion signaling single molecule survey syndrome TIMP-3 TMS transcription factor transitional-cell carcinoma triazine Tumor suppressor genes tumorigenesis tumorigenic tumors tumour United States Univariate Workshop Zebularine |
PIBBS Homepage for Dr. Peter A. Jones PIBBS Homepage
| ©1998-2008 The University of Southern California |